Get the Stockscreener App
137.47
0.67%
0.92
After Hours:
137.47
Genedx Holdings Corp stock is traded at $137.47, with a volume of 295.22K.
It is up +0.67% in the last 24 hours and down -13.97% over the past month.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
See More
Previous Close:
$136.55
Open:
$136.74
24h Volume:
295.22K
Relative Volume:
0.61
Market Cap:
$3.97B
Revenue:
$267.23M
Net Income/Loss:
$-83.50M
P/E Ratio:
-44.20
EPS:
-3.11
Net Cash Flow:
$-59.99M
1W Performance:
+5.70%
1M Performance:
-13.97%
6M Performance:
+61.31%
1Y Performance:
+42.35%
1-Day Range:
$133.35
$137.97
1-Week Range:
$124.26
$139.00
52-Week Range:
$55.17
$170.87
Genedx Holdings Corp Stock (WGS) Company Profile
Name
Genedx Holdings Corp
Sector
Industry
Phone
888-729-1206
Address
333 LUDLOW STREET, STAMFORD
Compare WGS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
137.47 | 3.95B | 267.23M | -83.50M | -59.99M | -3.11 |
|
TMO
Thermo Fisher Scientific Inc
|
606.50 | 231.87B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.00 | 166.39B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
712.39 | 57.06B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
243.19 | 41.60B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
145.76 | 41.90B | 6.95B | 1.30B | 1.15B | 4.5696 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-25 | Initiated | Canaccord Genuity | Buy |
| Jul-09-25 | Initiated | Piper Sandler | Overweight |
| May-15-25 | Initiated | Guggenheim | Buy |
| May-09-25 | Upgrade | Jefferies | Hold → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-10-24 | Initiated | Craig Hallum | Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
View All
Genedx Holdings Corp Stock (WGS) Latest News
Is GeneDx Holdings Corp. Equity Warrant stock positioned for digital transformation2025 Trading Volume Trends & Advanced Swing Trade Entry Plans - ulpravda.ru
Why GeneDx Holdings Corp. stock could rally in 2025Portfolio Return Report & Real-Time Buy Signal Notifications - ulpravda.ru
GeneDx partners with Komodo Health to create comprehensive rare disease dataset - Investing.com Canada
New rare disease database links DNA and real-world care for 330M patients - Stock Titan
How GeneDx Holdings Corp. stock reacts to job market dataDividend Yield Trends & Free Unlock Rapid Growth Potential - ulpravda.ru
GeneDx Announces GenomeDx Prenatal, Expanding Genomic Diagnosis into Prenatal Care - MarketScreener
GeneDx to launch whole genome sequencing test for fetal anomalies By Investing.com - Investing.com Canada
New prenatal genome test offers faster answers after troubling ultrasounds - Stock Titan
A Look At GeneDx Holdings (WGS) Valuation After New CMO Appointment And Record Rare Disease Genomics Year - Yahoo Finance
GeneDx appoints Dr. Linda Genen as CMO - MSN
GeneDx Holdings Corp.Class A Common Stock (NQ: WGS - FinancialContent
GeneDx appoints Linda Genen as chief medical officer By Investing.com - Investing.com Australia
GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care (2026-01-06) - Seeking Alpha
Should GeneDx’s GUARDIAN Newborn Genomics Accolade Reshape the Investment Narrative for WGS Investors? - simplywall.st
Genomic newborn screening may find serious diseases traditional tests miss - Stock Titan
(WGS) and the Role of Price-Sensitive Allocations - Stock Traders Daily
GeneDx Holdings Corp. (NASDAQ:WGS) Q4 2024 Earnings Call Transcript - MSN
What Do Analysts Think About GeneDx Holdings Corp. (WGS)? - Insider Monkey
Simplify Asset Management Inc. Sells 41,071 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference - MarketScreener
Ajooni Biotech Limited Uptrend in Early Stages Indicators Say YesVolatility Index Analysis & You’ve Never Seen Stock Picks Like These - earlytimes.in
GeneDx Holdings Corp. $WGS Shares Sold by Harbor Capital Advisors Inc. - MarketBeat
Assenagon Asset Management S.A. Has $1.52 Million Stock Position in GeneDx Holdings Corp. $WGS - MarketBeat
Behavioral Patterns of WGS and Institutional Flows - Stock Traders Daily
What analysts say about GeneDx Holdings Corp Equity Warrant stockReal Estate Investment Trusts & Rapid Portfolio Appreciation - earlytimes.in
WGS FinancialsIncome Statement - Quiver Quantitative
GeneDx Holdings (WGS) Sees Analyst Rating Update: Price Target R - GuruFocus
Canaccord Genuity Group Forecasts Strong Price Appreciation for GeneDx (NASDAQ:WGS) Stock - MarketBeat
Aug EndMonth: Is GeneDx Holdings Corp. Equity Warrant stock positioned well for digital economy2025 Price Action Summary & Free AI Powered Buy and Sell Recommendations - moha.gov.vn
Is JAMA’s GUARDIAN Nod Quietly Reframing GeneDx (WGS) as a Core Newborn Genomics Platform? - simplywall.st
Is GeneDx Holdings Corp. Equity Warrant stock a safe buy before earnings2025 Winners & Losers & Low Drawdown Investment Strategies - Улправда
Investment Report: How GeneDx Holdings Corp. Equity Warrant stock reacts to job market data2025 Top Gainers & Weekly High Conviction Trade Ideas - Улправда
GeneDx (WGS) Valuation Check as JAMA Highlights GUARDIAN Newborn Genomic Screening Study - simplywall.st
How GeneDx Holdings Corp. Equity Warrant stock reacts to job market data2025 Year in Review & Real-Time Buy Signal Notifications - Улправда
How sustainable is GeneDx Holdings Corp. stock dividend payoutJuly 2025 Earnings & Low Drawdown Trading Techniques - Улправда
Can GeneDx Holdings Corp. stock beat market expectations this quarter2025 Top Decliners & Low Risk Entry Point Guides - Улправда
Risk Report: Is GeneDx Holdings Corp. Equity Warrant stock attractive for income investors2025 Geopolitical Influence & Accurate Intraday Trading Signals - Улправда
Why analysts upgrade GeneDx Holdings Corp. stockJuly 2025 Analyst Calls & Free High Return Stock Watch Alerts - Улправда
Is GeneDx Holdings Corp. Equity Warrant stock positioned well for digital economyJuly 2025 Setups & Growth Oriented Trade Recommendations - Улправда
GeneDx (NASDAQ:WGS) CEO Katherine Stueland Sells 10,857 Shares - MarketBeat
Insider Selling: GeneDx (NASDAQ:WGS) CFO Sells 3,855 Shares of Stock - MarketBeat
GeneDx Holdings Corp. Executives Sell Shares for Tax Obligations - TradingView — Track All Markets
CFO Feeley Acquires 3,342 Of GeneDx Holdings Corp [WGS] - TradingView — Track All Markets
GeneDx Holdings Corp. (WGS) CFO reports RSU vesting and sell-to-cover trades - Stock Titan
GeneDx (WGS) CEO discloses RSU vesting, tax-related stock sales - Stock Titan
Can GeneDx Holdings Corp. Equity Warrant stock surprise with earnings upsideJuly 2025 Opening Moves & AI Forecast for Swing Trade Picks - Улправда
GeneDx (WGS) Stock Slides on Dec. 16, 2025: Latest News, Analyst Forecasts, and What Investors Are Watching Next - ts2.tech
GeneDx (NASDAQ:WGS) Stock Price Down 6.4%What's Next? - MarketBeat
WGS: Wells Fargo Raises Price Target to $155, Maintains Equal-We - GuruFocus
GeneDx (Nasdaq: WGS) genomic newborn study in JAMA list after 20K screens - Stock Titan
GeneDx Holdings Corp. (NASDAQ:WGS) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Genedx Holdings Corp Stock (WGS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.37%
2.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):